Authors/Disclosures
|
Saud I. Khan, MD
(Titus Regional Medical Center)
|
Dr. Khan has nothing to disclose. |
|
Giulio M. Pasinetti, MD, PhD
(Mount Sinai School of Medicine)
|
No disclosure on file |
|
Lynne Love, MD
|
No disclosure on file |
|
Carlayne E. Jackson, MD, FÂ鶹´«Ã½Ó³»
(University of Texas Health Science Center at San Antonio)
|
Dr. Jackson has received personal compensation in the range of $100,000-$499,999 for serving as an officer or member of the Board of Directors for Â鶹´«Ã½Ó³». The institution of Dr. Jackson has received research support from NIH. The institution of Dr. Jackson has received research support from Massachussetts General Hospital. |
|
John T. Kissel, MD, FÂ鶹´«Ã½Ó³»
|
Dr. Kissel has nothing to disclose. |
|
Kelly G. Knupp, MD
(Children's Hospital Colorado)
|
The institution of Dr. Knupp has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Harmony. Dr. Knupp has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Epilepsy Research. |
|
Gil I. Wolfe, MD, FÂ鶹´«Ã½Ó³»
(Univ. At Buffalo, SUNY)
|
Dr. Wolfe has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Grifols. Dr. Wolfe has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Alexion. Dr. Wolfe has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for ArgenX. Dr. Wolfe has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for UCB/Ra. Dr. Wolfe has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Janssen. Dr. Wolfe has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Cartesian. Dr. Wolfe has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Grifols. The institution of Dr. Wolfe has received research support from UCB/Ra. The institution of Dr. Wolfe has received research support from Immunovant. The institution of Dr. Wolfe has received research support from Roche. Dr. Wolfe has received personal compensation in the range of $0-$499 for serving as a Advisor with FDA Advisory Panel for Cellular, Tissue and Genetic Therapies. |
|
Sharon P. Nations, MD, FÂ鶹´«Ã½Ó³»
|
No disclosure on file |
|
Jaya Trivedi, MD, FÂ鶹´«Ã½Ó³»
(UT Southwestern Medical Center)
|
The institution of Dr. Trivedi has received research support from Avidity. |
|
Mike Singer, MD, PhD
(FDA)
|
No disclosure on file |
|
Arie F. Struyk, MD, PhD
(Merck & Co., Inc.)
|
No disclosure on file |
|
Jeffrey L. Elliott, MD
(UT Southwestern Medical Center)
|
No disclosure on file |
|
Steven Vernino, MD, PhD, FÂ鶹´«Ã½Ó³»
(UT Southwestern Medical Center)
|
Dr. Vernino has received personal compensation in the range of $500-$4,999 for serving as a Consultant for lundbeck. Dr. Vernino has received personal compensation in the range of $500-$4,999 for serving as a Consultant for CSL Behring. Dr. Vernino has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Regeneron. Dr. Vernino has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for argenx. Dr. Vernino has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alterity. Dr. Vernino has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Autonomic Neuroscience (Elsevier). The institution of Dr. Vernino has received research support from Takeda. The institution of Dr. Vernino has received research support from NIH/NHLBI. The institution of Dr. Vernino has received research support from Lundbeck. The institution of Dr. Vernino has received research support from Regeneron. |
|
Mamatha Pasnoor, MD, FÂ鶹´«Ã½Ó³»
|
Dr. Pasnoor has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Argenx BVBA. Dr. Pasnoor has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Janssen Pharmaceutical. Dr. Pasnoor has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Immunovant. Dr. Pasnoor has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UCB. Dr. Pasnoor has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Annexon. Dr. Pasnoor has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Grifols. Dr. Pasnoor has received personal compensation in the range of $500-$4,999 for serving as a Consultant for amgen. |
|
Reddiah B. Mummaneni, MD
(Cedar Park Neurology)
|
No disclosure on file |
|
Laura Herbelin
(KU Medical Center)
|
No disclosure on file |
|
David S. Saperstein, MD
(Center for Complex Neurology, EDS & POTS)
|
No disclosure on file |
|
Gary S. Gronseth, MD, FÂ鶹´«Ã½Ó³»
(University of Kansas)
|
Dr. Gronseth has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Brain & Life. Dr. Gronseth has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Neurology. Dr. Gronseth has received personal compensation in the range of $0-$499 for serving as a Member/EBM consultant Guideline Development Subcommittee with Â鶹´«Ã½Ó³». |
|
April L. McVey, MD
(April L. McVey, MD)
|
No disclosure on file |
|
Richard J. Barohn, MD, FÂ鶹´«Ã½Ó³»
(University of Missouri)
|
Dr. Barohn has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for NuFactor. The institution of Dr. Barohn has received research support from FDA OPD R01. Dr. Barohn has received intellectual property interests from a discovery or technology relating to health care. |